已发表论文

模拟恶性淋巴瘤的孤立的颅内髓样肉瘤:诊断挑战和文献回顾

 

Authors Xu G, Zhang H, Nong W, Li C, Meng L, Liu C, Li F

Received 13 January 2020

Accepted for publication 18 May 2020

Published 25 June 2020 Volume 2020:13 Pages 6085—6092

DOI https://doi.org/10.2147/OTT.S245828

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Editor who approved publication: Dr Sanjay Singh

Abstract: Isolated intracranial myeloid sarcoma (MS) is an unusual variant tumor with few cases reported so far in the medical literature. A 29-year-old woman was admitted to our hospital presenting progressive visual loss in the right eye and weight loss (20 kg) without a previous history of hematological disease (HD). Radiologic evaluation showed the evidence of intracranial mass. Histologically, the resected tumor was composed of a uniform population of primitive cells and primarily misdiagnosed as a T-cell non-Hodgkin’s lymphoma (NHL). Chemotherapy with cyclophosphamide, doxorubicin, vinblastine, and prednisone (CHOP) was ineffective. A biopsy and histopathological evaluation were repeated, and immunohistochemical staining revealed the positivity of immature cells to an extensive panel of myeloid markers. These findings were consistent with a diagnosis of MS and bone marrow infiltration. Literature reviews of previous cases were also undertaken.
Keywords: myeloid sarcoma, isolated, intracranial, non-Hodgkin’s lymphoma, misdiagnosis




Figure 4 Bone marrow cell morphology...